Single-cell transcriptomics of tumor masses from engineered lung and pancreatic cancer models suggest that gain-of-function KRAS and loss-of-function TP53 mutations may not be responsible per se for generating the fully malignant phenotype [4, 8, 9, 11, 12]. This evidence concerns the gene TP53 and neoplasm.